| 摘要 |
<p>The invention relates to a transdermal therapeutic system comprising a back layer which is inert with respect to the constituents of the matrix, a selfadhesive matrix layer containing an effective quantity of (-)-5,6,7,8,-tetrahydro-6-¢propyl¢2-(2-thienyl)-ethyl!amino!-1-naphthol, and a protective film which is to be removed before use. The invention is characterized by a matrix based on a non-aqueous polymer adhesive system, said system being based on acrylate or silicon, with a solubility for (-)-5,6,7,8,-tetrahydro-6-¢propyl¢2-(2-thienyl)-ethyl!amino!-1-naphthol of 5 % g/g. Said matrix is essentially free of inorganic silicate particles.</p> |
